Shares of Guardant Health Inc. (GH) fell sharply by 5.11% in the pre-market session on Friday, as the company reported disappointing financial results for the quarter ended December 31, 2024.
According to the earnings report, Guardant Health posted an adjusted loss of $0.90 per share, missing analysts' expectations of a loss of $0.74 per share. The company's revenue grew 30.2% year-over-year to $201.81 million, but still fell short of the consensus estimate of $192.14 million.
The disappointing earnings performance and failure to meet Wall Street's estimates appear to have triggered the sharp sell-off in Guardant Health's stock. Investors may have concerns about the company's profitability and growth prospects, as it continues to report significant losses despite revenue growth.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。